Medications

Farxiga approved to reduce risk for CKD progression

(HealthDay)—Farxiga (dapagliflozin) oral tablets are now approved for adults with chronic kidney disease at risk for disease progression, the U.S. Food and Drug Administration announced Friday.

Diseases, Conditions, Syndromes

COVID-19 vaccine hesitancy among patients undergoing dialysis

In a nationwide survey of U.S. patients undergoing dialysis, one-fifth of patients were hesitant to receive a COVID-19 vaccine, and hesitancy was especially high among certain age and minority racial and ethnic groups. The ...

Diseases, Conditions, Syndromes

The impact of COVID-19 on people with kidney failure

A new analysis reveals that individuals with kidney failure have faced especially high hospitalization and death rates during the COVID-19 pandemic. The findings, which appear in an upcoming issue of JASN, support prioritization ...

Diseases, Conditions, Syndromes

Cycling study transforms heart health of dialysis patients

Cycling at moderate intensity during dialysis could drastically improve the heart health of patients with kidney failure and result in significant savings for the NHS, according to new research by the University of Leicester ...

page 30 from 40